Rare diseases
Investigational molecules
Locations
Back to Czechia50 clinical trials in Teplice, Czechia across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)Orelabrutinib in Patients with Primary Progressive Multiple Sclerosis
CzechiaEffect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)
CzechiaGB-0895 for Severe Uncontrolled Asthma in Adults and Adolescents
CzechiaComparison of Obicetrapib and Bempedoic Acid in Patients with Dyslipidemia at High to Very High Cardiovascular Risk
CzechiaA study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis
CzechiaStudy of BMS-986368 to treat muscle stiffness in people with Multiple Sclerosis
CzechiaStudy of Tezepelumab Compared to Placebo in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)
CzechiaStudy on the Effects of Vidofludimus Calcium (IMU-838) in Patients with Progressive Multiple Sclerosis
CzechiaStudy on Efepoetin Alfa and Darbepoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis
CzechiaStudy on the Effectiveness of Lenzumestrocel for Treating Knee Cartilage Defects in Patients
CzechiaCzechiaStudy on Long-Term Safety of Tolebrutinib and Teriflunomide for Patients with Multiple Sclerosis
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical research focusing on severe asthma and COPD treatments, evaluating new therapeutic approaches for patients with uncontrolled symptoms. Studies are examining various inhaler formulations and novel biological treatments to improve lung function and reduce exacerbations.
Multiple trials are investigating both established and experimental medications for treating moderate to severe respiratory conditions.
Comprehensive research programs investigating treatments for Multiple Sclerosis, including both relapsing-remitting and progressive forms. Studies are evaluating new therapeutic approaches and comparing different administration methods for existing treatments.
Advanced clinical trials focusing on improving treatment options and patient outcomes in neurological conditions.
Research initiatives examining treatments for Hypertriglyceridemia and related metabolic conditions. Studies are focused on evaluating the safety and efficacy of new therapeutic agents for managing lipid disorders.
Innovative clinical trials aimed at developing more effective treatments for metabolic disorders.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
